眼硬度与贝伐珠单抗玻璃体腔注射后眼压峰值相关
这项前瞻性横断面研究纳入18例因渗出性视网膜病变接受贝伐珠单抗玻璃体腔注射的眼,用视频速率OCT和动态轮廓眼压计无创测量眼硬度(OR),注射前后用Tono-Pen XL测眼压。结果显示注射后眼压平均升高19±9 mmHg,OR与眼压升高的Spearman相关系数为0.796(p<0.001),提示OR可预测注射后眼压峰值。
要点
- 抗VEGF玻璃体腔注射后眼压平均升高19±9 mmHg,范围7–33 mmHg。
- OR与注射后眼压升高的Spearman相关系数为0.796(p<0.001),眼越硬眼压升高越明显。
- 无创测量OR或有助于识别注射后眼压峰值风险患者。
核心结论
- 眼硬度(OR)与抗VEGF玻璃体腔注射后急性眼压升高呈强正相关。
- 无创测量OR可能成为识别注射后眼压峰值风险患者的有效工具。
研究设计与样本
- 前瞻性横断面研究,纳入18例因既存视网膜病变需接受抗VEGF玻璃体腔注射的受试者,共18眼。
- 用视频速率光学相干断层扫描测量搏动性脉络膜体积变化、动态轮廓眼压计测量搏动性眼压变化以评估OR。
- 用Tono-Pen XL在注射前和注射后即刻测量眼压,并与OR进行相关性分析。
主要发现
- 玻璃体腔注射后眼压平均升高19±9 mmHg,范围为7–33 mmHg。
- OR与注射后眼压升高的Spearman相关系数为0.796(p<0.001)。
- 眼硬度更高的眼,注射后眼压升高更明显。
- 基于OR系数计算回归线预测眼压峰值:眼压峰值=664.17 mmHg·µL×OR+4.59 mmHg。
关键数值与推荐
- OR与注射后眼压升高的Spearman相关系数为0.796(p<0.001)。
- 注射后眼压平均升高19±9 mmHg,范围7–33 mmHg。
- 预测回归方程:眼压峰值=664.17 mmHg·µL×OR+4.59 mmHg。
临床怎么用
- 对需行抗VEGF玻璃体腔注射的患者,可考虑无创测量OR以评估注射后眼压峰值风险。
- 注射后即刻测量眼压有助于发现眼压升高,尤其在高OR患者中。
局限性
- 样本量仅18眼,结论需更大样本验证。
- 研究为横断面设计,OR预测眼压峰值的效能需前瞻性验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND/AIMS: To evaluate the non-invasive measurement of ocular rigidity (OR), an important biomechanical property of the eye, as a predictor of intraocular pressure (IOP) elevation after anti-vascular endothelial growth factor (anti-VEGF) intravitreal injection (IVI). METHODS: Subjects requiring IVI of anti-VEGF for a pre-existing retinal condition were enrolled in this prospective cross-sectional study. OR was assessed in 18 eyes of 18 participants by measurement of pulsatile choroidal volume change using video-rate optical coherence tomography, and pulsatile IOP change using dynamic contour tonometry. IOP was measured using Tono-Pen XL before and immediately following the injection and was correlated with OR. RESULTS: The average increase in IOP following IVI was 19±9 mm Hg, with a range of 7-33 mm Hg. The Spearman correlation coefficient between OR and IOP elevation following IVI was 0.796 (p<0.001), showing higher IOP elevation in more rigid eyes. A regression line was also calculated to predict the IOP spike based on the OR coefficient, such that IOP spike=664.17 mm Hg·µL×OR + 4.59 mm Hg. CONCLUSION: This study shows a strong positive correlation between OR and acute IOP elevation following IVI. These findings indicate that the non-invasive measurement of OR could be an effective tool in identifying patients at risk of IOP spikes following IVI.
引用
- Sayah DN, Szigiato AA, Mazzaferri J, et al. Correlation of ocular rigidity with intraocular pressure spike after intravitreal injection of bevacizumab in exudative retinal disease. Br J Ophthalmol. 2020. PMID: 32345604. doi:10.1136/bjophthalmol-2019-315595
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。